Mahbubur Rahman1, Lee B Elam, Michael I Balat, Abbey B Berenson. 1. Department of Obstetrics and Gynecology and the Center for Interdisciplinary Research in Women's Health, University of Texas Medical Branch, Galveston, TX, United States. Electronic address: marahman@utmb.edu.
Abstract
OBJECTIVE: To examine the association between attending a well-woman clinic in the prior 2 years and obtaining the human papillomavirus (HPV) vaccine for their 9-17-year-old child. METHODS: Women (n=1256) who attended reproductive health clinics during September 2011 to February 2013 and had ≥1 children 9-17 years of age were asked to complete a self-administered questionnaire containing questions on demographic characteristics, prior well-woman visits, HPV awareness, and HPV vaccine intent and uptake among their adolescent children. RESULTS: Nearly 78% of women reported having undergone a well-woman visit during the past 2 years. Bivariate analysis showed that the HPV vaccine initiation (23.9% vs. 14.0%, P=.004) and completion (13.6% vs. 6.7%, P=.011) among 9-17 daughters differed between mothers who did or did not have a well-woman visit during the past 2 years. However, intent to vaccinate them (47.2% vs. 53.3%, P=.173) did not differ between these two groups. With regard to 9-17 year old sons, vaccine initiation (10.1% vs. 9.6%, P=.871), completion (4.6% vs. 2.4%, P=.273) and intent to vaccinate (47.3% vs. 52.1%, P=.311) did not differ between these two groups. Multivariable logistic regression analyses confirmed the findings of these bivariate analyses after adjusting for confounder variables. CONCLUSION: The well-woman visit may be a missed opportunity for physicians to educate their patients about the benefits of HPV vaccination for their adolescent children in general and sons in particular. Intervention studies are warranted to assess the benefits of using this setting to improve HPV vaccine uptake in the US.
OBJECTIVE: To examine the association between attending a well-woman clinic in the prior 2 years and obtaining the human papillomavirus (HPV) vaccine for their 9-17-year-old child. METHODS:Women (n=1256) who attended reproductive health clinics during September 2011 to February 2013 and had ≥1 children 9-17 years of age were asked to complete a self-administered questionnaire containing questions on demographic characteristics, prior well-woman visits, HPV awareness, and HPV vaccine intent and uptake among their adolescent children. RESULTS: Nearly 78% of women reported having undergone a well-woman visit during the past 2 years. Bivariate analysis showed that the HPV vaccine initiation (23.9% vs. 14.0%, P=.004) and completion (13.6% vs. 6.7%, P=.011) among 9-17 daughters differed between mothers who did or did not have a well-woman visit during the past 2 years. However, intent to vaccinate them (47.2% vs. 53.3%, P=.173) did not differ between these two groups. With regard to 9-17 year old sons, vaccine initiation (10.1% vs. 9.6%, P=.871), completion (4.6% vs. 2.4%, P=.273) and intent to vaccinate (47.3% vs. 52.1%, P=.311) did not differ between these two groups. Multivariable logistic regression analyses confirmed the findings of these bivariate analyses after adjusting for confounder variables. CONCLUSION: The well-woman visit may be a missed opportunity for physicians to educate their patients about the benefits of HPV vaccination for their adolescent children in general and sons in particular. Intervention studies are warranted to assess the benefits of using this setting to improve HPV vaccine uptake in the US.
Authors: J M Walboomers; M V Jacobs; M M Manos; F X Bosch; J A Kummer; K V Shah; P J Snijders; J Peto; C J Meijer; N Muñoz Journal: J Pathol Date: 1999-09 Impact factor: 7.996
Authors: Eileen F Dunne; Carrie M Nielson; Katherine M Stone; Lauri E Markowitz; Anna R Giuliano Journal: J Infect Dis Date: 2006-09-12 Impact factor: 5.226
Authors: Lauri E Markowitz; Eileen F Dunne; Mona Saraiya; Herschel W Lawson; Harrell Chesson; Elizabeth R Unger Journal: MMWR Recomm Rep Date: 2007-03-23
Authors: Eileen F Dunne; Elizabeth R Unger; Maya Sternberg; Geraldine McQuillan; David C Swan; Sonya S Patel; Lauri E Markowitz Journal: JAMA Date: 2007-02-28 Impact factor: 56.272
Authors: L Ebony Boulware; Spyridon Marinopoulos; Karran A Phillips; Constance W Hwang; Kenric Maynor; Dan Merenstein; Renee F Wilson; George J Barnes; Eric B Bass; Neil R Powe; Gail L Daumit Journal: Ann Intern Med Date: 2007-02-20 Impact factor: 25.391
Authors: Gregory D Zimet; Susan M Perkins; Lynne A Sturm; Rita M Bair; Beth E Juliar; Rose M Mays Journal: J Adolesc Health Date: 2005-09 Impact factor: 5.012